Why Mira Pharmaceuticals Shares Rose 69% After Hours?

Benzinga_recent_news10-16

Mira Pharmaceuticals Inc. (NASDAQ:MIRA) shares jumped 68.94% to $2.23 in after-hours trading on Wednesday. Check out the current price of MIRA stock here. On Wednesday, Mira Pharmaceuticals submitted ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2575999537?lang=en_US&edition=fundamental","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/10/16/Stock-Graph-With-Green-Candle-Spike.jpeg?optimize=medium&dpr=2&auto=webp&width=240","is_english":true,"pubTime":"2025-10-16 13:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2575999537","market":"us","top_or_hot":-1,"title":"Why Mira Pharmaceuticals Shares Rose 69% After Hours?","media":"Benzinga_recent_news","content":"<div>\n<p>Mira Pharmaceuticals Inc. (NASDAQ:MIRA) shares jumped 68.94% to $2.23 in after-hours trading on Wednesday.\nCheck out the current price of MIRA stock here.\nOn Wednesday, Mira Pharmaceuticals submitted ...</p>\n\n<a href=\"https://www.benzinga.com/markets/equities/25/10/48242497/why-mira-pharmaceuticals-shares-rose-69-after-hours\">Source Link</a>\n\n</div>\n","source":"benzinga_recent_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Mira Pharmaceuticals Shares Rose 69% After Hours?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Mira Pharmaceuticals Shares Rose 69% After Hours?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-10-16 13:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/markets/equities/25/10/48242497/why-mira-pharmaceuticals-shares-rose-69-after-hours><strong>Benzinga_recent_news</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Mira Pharmaceuticals Inc. (NASDAQ:MIRA) shares jumped 68.94% to $2.23 in after-hours trading on Wednesday.\nCheck out the current price of MIRA stock here.\nOn Wednesday, Mira Pharmaceuticals submitted ...</p>\n\n<a href=\"https://www.benzinga.com/markets/equities/25/10/48242497/why-mira-pharmaceuticals-shares-rose-69-after-hours\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MIRA","symbol_name":"Mira Pharma","start_time":0,"source_url":"https://www.benzinga.com/markets/equities/25/10/48242497/why-mira-pharmaceuticals-shares-rose-69-after-hours","article_id":"2575999537","we_media_id":null,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/10/16/Stock-Graph-With-Green-Candle-Spike.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/equities/25/10/48242497/why-mira-pharmaceuticals-shares-rose-69-after-hours","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2575999537","pubTimestamp":1760591700,"columns":[],"sourceInfo":{"source_id":"benzinga_recent_news","name":"Benzinga"},"weMediaInfo":null,"summary":"Mira Pharmaceuticals shares surged 68.94% in after-hours trading after the company reported promising preclinical results for its pain treatment candidate, Mira-55.","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"MIRA":"Mira Pharma","BK4007":"制药"},"translate_title":"为什么Mira Pharmaceuticals股价盘后上涨69%？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MIRA":1.5},"content_text":"Mira Pharmaceuticals Inc. (NASDAQ:MIRA) shares jumped 68.94% to $2.23 in after-hours trading on Wednesday.\nCheck out the current price of MIRA stock here.\nOn Wednesday, Mira Pharmaceuticals submitted an 8-K filing with the Securities and Exchange Commission revealing new preclinical results for Mira-55, its proprietary non-psychotropic marijuana compound.\nThe study found that orally administered Mira-55 reduced inflammation and normalized pain levels, outperforming injected morphine in an animal model of chronic inflammatory pain.\nIn preclinical studies, oral Mira-55 was shown to restore pain sensitivity to normal levels and performed better than injected morphine in reducing pain caused by formalin. It also significantly reduced inflammation by targeting CB2 receptors, whereas morphine only partially reduced swelling through indirect effects on the central nervous system.\nSee Also: Cathie Wood Goes Big On Chinese Tech: Ark Invest Places $26 Million Bet On Alibaba And Baidu, Dumps Palantir Stock\nThe results support the Florida-based company's plans to move forward with an Investigational New Drug application for chronic inflammatory pain. \nIn its filing, MIRA highlighted the $70 billion non-opioid pain market as a key opportunity.\nMIRA reported its second-quarter earnings on Aug. 14, posting a loss of 9 cents per share, beating analyst estimates of a 12-cent loss. The company reported no revenue for the quarter. Its next earnings report is scheduled for Nov. 11.\nMira Pharmaceuticals has gained 20% over the past year and 0.76% in the past month. On Wednesday, 3.7 million shares were traded, well above the stock's average daily volume of 661,120.\nThe clinical-stage pharmaceutical company has traded between $0.73 and $2.56 over the past year and currently holds a market capitalization of $25.37 million.\nPrice Action: According to Benzinga Pro data, MIRA closed at $1.32 on Wednesday, up 0.76%.\nWith momentum in the 77th percentile, Benzinga's Edge Stock Rankings indicate that MIRA is experiencing short- and medium-term consolidation, alongside a long-term upward trend. Know how its momentum lines up with other well-known names.\nRead Next:\nPhoto Courtesy: Jose Mario Bertero on Shutterstock.com\nDisclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2575999537","isCrawlerRequest":true}